科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/11/10 | 4,325 | 4,330 | 4,280 | 4,295 | +40 | +0.9% | 63,100 |
| 2021/11/09 | 4,240 | 4,275 | 4,220 | 4,255 | +55 | +1.3% | 93,700 |
| 2021/11/08 | 4,285 | 4,295 | 4,195 | 4,200 | -155 | -3.6% | 105,900 |
| 2021/11/05 | 4,350 | 4,370 | 4,285 | 4,355 | -135 | -3% | 118,800 |
| 2021/11/04 | 4,575 | 4,580 | 4,360 | 4,490 | -15 | -0.3% | 179,800 |
| 2021/11/02 | 4,500 | 4,540 | 4,485 | 4,505 | -65 | -1.4% | 69,200 |
| 2021/11/01 | 4,590 | 4,590 | 4,530 | 4,570 | +80 | +1.8% | 78,500 |
| 2021/10/29 | 4,485 | 4,500 | 4,430 | 4,490 | -10 | -0.2% | 83,700 |
| 2021/10/28 | 4,515 | 4,520 | 4,485 | 4,500 | -20 | -0.4% | 344,800 |
| 2021/10/27 | 4,520 | 4,545 | 4,500 | 4,520 | +30 | +0.7% | 110,100 |
| 2021/10/26 | 4,460 | 4,520 | 4,455 | 4,490 | +10 | +0.2% | 79,400 |
| 2021/10/25 | 4,480 | 4,540 | 4,475 | 4,480 | ±0 | ±0% | 79,100 |
| 2021/10/22 | 4,465 | 4,520 | 4,460 | 4,480 | -25 | -0.6% | 101,700 |
| 2021/10/21 | 4,495 | 4,580 | 4,475 | 4,505 | +30 | +0.7% | 163,000 |
| 2021/10/20 | 4,485 | 4,500 | 4,445 | 4,475 | -5 | -0.1% | 73,000 |
| 2021/10/19 | 4,440 | 4,480 | 4,440 | 4,480 | +55 | +1.2% | 59,400 |
| 2021/10/18 | 4,490 | 4,495 | 4,420 | 4,425 | -115 | -2.5% | 76,300 |
| 2021/10/15 | 4,430 | 4,545 | 4,430 | 4,540 | +85 | +1.9% | 72,600 |
| 2021/10/14 | 4,425 | 4,490 | 4,415 | 4,455 | +35 | +0.8% | 103,700 |
| 2021/10/13 | 4,420 | 4,430 | 4,385 | 4,420 | +40 | +0.9% | 94,900 |
| 2021/10/12 | 4,475 | 4,490 | 4,380 | 4,380 | -120 | -2.7% | 72,900 |
| 2021/10/11 | 4,485 | 4,515 | 4,475 | 4,500 | ±0 | ±0% | 57,100 |
| 2021/10/08 | 4,495 | 4,545 | 4,485 | 4,500 | +5 | +0.1% | 88,200 |
| 2021/10/07 | 4,530 | 4,550 | 4,490 | 4,495 | -35 | -0.8% | 101,300 |
| 2021/10/06 | 4,450 | 4,545 | 4,445 | 4,530 | +60 | +1.3% | 96,200 |
| 2021/10/05 | 4,550 | 4,555 | 4,460 | 4,470 | -105 | -2.3% | 133,800 |
| 2021/10/04 | 4,565 | 4,580 | 4,525 | 4,575 | +65 | +1.4% | 78,600 |
| 2021/10/01 | 4,595 | 4,615 | 4,510 | 4,510 | -85 | -1.8% | 90,800 |
| 2021/09/30 | 4,600 | 4,650 | 4,575 | 4,595 | +35 | +0.8% | 98,300 |
| 2021/09/29 | 4,600 | 4,600 | 4,510 | 4,560 | -125 | -2.7% | 198,200 |
| 2021/09/28 | 4,735 | 4,735 | 4,675 | 4,685 | -70 | -1.5% | 127,400 |
| 2021/09/27 | 4,850 | 4,850 | 4,755 | 4,755 | -95 | -2% | 153,800 |
| 2021/09/24 | 4,845 | 4,880 | 4,830 | 4,850 | +60 | +1.3% | 103,300 |
| 2021/09/22 | 4,830 | 4,855 | 4,790 | 4,790 | -25 | -0.5% | 159,800 |
| 2021/09/21 | 4,870 | 4,870 | 4,815 | 4,815 | -60 | -1.2% | 103,100 |
| 2021/09/17 | 4,890 | 4,920 | 4,850 | 4,875 | -15 | -0.3% | 321,500 |
| 2021/09/16 | 4,890 | 4,895 | 4,845 | 4,890 | +5 | +0.1% | 145,500 |
| 2021/09/15 | 4,930 | 4,955 | 4,885 | 4,885 | -110 | -2.2% | 146,000 |
| 2021/09/14 | 4,990 | 5,010 | 4,950 | 4,995 | ±0 | ±0% | 87,700 |
| 2021/09/13 | 4,970 | 4,995 | 4,935 | 4,995 | -45 | -0.9% | 112,800 |
| 2021/09/10 | 5,010 | 5,040 | 5,000 | 5,040 | +10 | +0.2% | 124,200 |
| 2021/09/09 | 5,050 | 5,080 | 5,010 | 5,030 | -40 | -0.8% | 69,000 |
| 2021/09/08 | 5,130 | 5,130 | 5,050 | 5,070 | -80 | -1.6% | 142,400 |
| 2021/09/07 | 5,200 | 5,240 | 5,130 | 5,150 | +30 | +0.6% | 101,500 |
| 2021/09/06 | 5,110 | 5,140 | 5,090 | 5,120 | +60 | +1.2% | 75,800 |
| 2021/09/03 | 5,000 | 5,100 | 5,000 | 5,060 | +50 | +1% | 112,200 |
| 2021/09/02 | 5,040 | 5,050 | 4,995 | 5,010 | -60 | -1.2% | 75,600 |
| 2021/09/01 | 4,995 | 5,080 | 4,975 | 5,070 | +100 | +2% | 87,100 |
| 2021/08/31 | 4,970 | 5,010 | 4,920 | 4,970 | -40 | -0.8% | 187,300 |
| 2021/08/30 | 5,000 | 5,020 | 4,980 | 5,010 | +20 | +0.4% | 119,900 |
851～
900
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
